logo image
search icon
Molecular Pharming Market

Molecular Pharming Market Size, Share & Trends Analysis Report By Technology (Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer), By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products), By Crop Source, By End User, By Region, And Segment Forecasts, 2024-2031

Report ID : 1712 | Published : 2024-06-07 | Pages: 180 | Format:

Molecular Pharming Market Size is valued at USD 1,574.6 Mn in 2023 and is predicted to reach USD 2,807.3 Mn by the year 2031 at a 7.8% CAGR during the forecast period for 2024-2031.


In a biotechnological program known as "molecular farming," crops are genetically altered to create proteins and chemicals for industrial and pharmaceutical uses. The vast majority of developing nations cannot pay the enormous price of medical treatments brought on by the already-used techniques. Farmers are urged by mounting environmental concerns to reorient their efforts toward sustainable agriculture methods, including resource conservation. This has increased the demand for better crop nutrition and protection, supporting market expansion.

molecular pharming

The molecular farming market growth is also anticipated to continue growing due to the rising demand for modern medicines and pharmaceuticals. Increasing environmental concerns are pressuring farmers to refocus their efforts on sustainable agriculture practices, including resource conservation. As a result, there is a tremendous need for improved crop nutrition and protection, which has helped the molecular farming industry to grow. 

Competitive Landscape:

Some of The Molecular Pharming Market Players Are: 

  • Agrenvec S.L
  • Bright Biotech
  • Core Biogenesis
  • Diamante SRL
  • Leaf Systems International Limited
  • Medicago Inc
  • Meristem Therapeutics S.A. (Ventria Bioscience)
  • Miruku
  • Moolec Science Limited
  • mozza
  • Nobell Foods
  • ORF Genetics
  • Pfizer, Inc.
  • ProdiGene Inc
  • Protalix Biotherapeutics, Inc
  • Tiamat Sciences 

Market Segmentation:

The molecular pharming market is segmented on the crop type, technology, applications and end users. The market is segmented based on crop type: maize, barley, tobacco, safflower, rice and alfalfa. Based on technology, the molecular pharming market is segmented into gene guns, agroinfiltration, electroporation, agrobacterium-mediated gene transfer and  Others. Based on the application, the molecular pharming market is segmented into recombinant antibodies, hormones, vaccines, industrial enzymes, proteins & protein-based materials, technical reagents, and nutritional products. Based on end-use, the molecular pharming market is segmented into biotechnology & pharmaceutical companies, contract manufacturing organizations, and others. 

Based On Technology, The Gene Gun Segment Is A Major Contributor To The Molecular Pharming Market

The market's leading segment is gene guns. A gene gun is a tool that is used to transport external (exogenous) DNA, RNA, or proteins to the cells in a way that allows the biological particles to be reproduced or translated using the plant reproduction system and to multiply the necessary biologics without the need of low-cost microbial systems.

The process known as agroinfiltration combines plant biotechnology and agriculture. To mass-create the desired protein, the approach simultaneously stimulates transitory gene expression in a plant, part of a plant, or numerous plants. A microbiological technique called electroporation, also referred to as electro-permeabilization, employs an electric field to make cells more permeable via their membranes. When utilized in plant biotechnology, these cells are preferably plant cells.

The Biotechnology & Pharmaceutical Companies Segment Witnessed Growth At A Rapid Rate

Biotechnology & pharmaceutical companies grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. Strong government support for the market is demonstrated by programs aiming to modernize the regulatory environment, enhance approval procedures and reimbursement practices, and standardize clinical studies. Biotechnological methods are expanding significantly, with examples including genetic engineering, DNA fingerprinting, and stem cell technologies.

The North American Molecular Pharming Market Holds A Significant Regional Revenue Share

The North American molecular pharming market is expected to register the highest market share in revenue shortly. The region's market has a high revenue due to factors including expanding government efforts that boost the implementation of modern agriculture technologies and established infrastructure. Additionally, a robust administrative framework helps farmers acquire the necessary skills for using and maintaining molecular farming equipment.

In addition, Asia Pacific is projected to grow rapidly in the global molecular pharming market. In emerging nations like India, Sri Lanka, and Nigeria, various government programs are being carried out to promote the adoption of cutting-edge molecular farming technologies and consequently increase productivity.

Recent Developments:

  • In April 2022, Satellite Bio introduced a unique method for bioengineering tissues. This company has expertise in synthetic biology, regenerative medicine, cell therapy, cell biology, and tissue engineering. 

Molecular Pharming Market Report Scope:

Report Attribute

Specifications

Market Size Value In 2023

USD 1,574.6 Mn

Revenue Forecast In 2031

USD 2,807.3 Mn

Growth Rate CAGR

CAGR of 7.8 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Crop Type, Technology, Applications And End Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea

Competitive Landscape

Meristem Therapeutics S.A. (Ventria Bioscience),, Moolec Science Limited, Leaf Systems International Limite, Agrenvec S.L, Diamante SRL, ORF Genetics, Pfizer, Inc., Medicago Inc, Protalix Biotherapeutics, Inc, ProdiGene Inc. and Other Market Players

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Molecular Pharming Market Snapshot

Chapter 4. Global Molecular Pharming Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:

5.2.1. Gene Gun
5.2.2. Agroinfiltration
5.2.3. Electroporation
5.2.4. Agrobacterium-Mediated Gene Transfer
5.2.5. Others

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

6.2.1. Recombinant Antibodies
6.2.2. Hormones
6.2.3. Vaccines
6.2.4. Industrial Enzymes
6.2.5. Proteins & Protein-Based Materials
6.2.6. Technical Reagents
6.2.7. Nutritional Products
6.2.8. Others

Chapter 7. Market Segmentation 3: by Crop Source Estimates & Trend Analysis
7.1. by Crop Source & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Crop Source:

7.2.1. Maize
7.2.2. Barley
7.2.3. Tobacco
7.2.4. Safflower
7.2.5. Rice
7.2.6. Alfalfa

Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:

8.2.1. Biotechnology & Pharmaceutical Companies
8.2.2. Contract Manufacturing Organizations
8.2.3. Others

Chapter 9. Molecular Pharming Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.1.2. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.1.3. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2024-2031
9.1.4. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
9.1.5. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.2. Europe

9.2.1. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.2.2. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.3. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2024-2031
9.2.4. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
9.2.5. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.3. Asia Pacific

9.3.1. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.3.2. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.3. Asia-Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2024-2031
9.3.4. Asia-Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
9.3.5. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.4. Latin America

9.4.1. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.4.2. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.4.3. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2024-2031
9.4.4. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
9.4.5. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.5. Middle East & Africa

9.5.1. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.5.2. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.3. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2024-2031
9.5.4. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
9.5.5. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Agrenvec S.L
10.2.2. Bright Biotech
10.2.3. Core Biogenesis
10.2.4. Diamante SRL
10.2.5. Leaf Systems International Limited
10.2.6. Medicago Inc
10.2.7. Meristem Therapeutics S.A. (Ventria Bioscience)
10.2.8. Miruku
10.2.9. Moolec Science Limited
10.2.10. mozza
10.2.11. Nobell Foods
10.2.12. ORF Genetics
10.2.13. Pfizer, Inc.
10.2.14. ProdiGene Inc
10.2.15. Protalix Biotherapeutics, Inc
10.2.16. Tiamat Sciences
10.2.17. Other Prominent Players

Segmentation of Molecular Pharming Market-

Molecular Pharming Market, By Crop Source:

  • Maize
  • Barley
  • Tobacco
  • Safflower
  • Rice
  • Alfalfa

molecular pharming

Molecular Pharming Market, By Technology:

  • Gene Gun
  • Agroinfiltration
  • Electroporation
  • Agrobacterium-Mediated Gene Transfer
  • Others

Molecular Pharming Market, By Application:

  • Recombinant Antibodies
  • Hormones
  • Vaccines
  • Industrial Enzymes
  • Proteins & Protein-Based Materials
  • Technical Reagents
  • Nutritional Products
  • Others

Molecular Pharming Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others

Molecular Pharming Market, By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Molecular Pharming Market Market?

Molecular Pharming Market Market expected tog grow at a 7.86% CAGR during the forecast period for 2024-2031

Meristem Therapeutics S.A. (Ventria Bioscience),, Moolec Science Limited, Leaf Systems International Limite, Agrenvec S.L

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach